Analytical and Clinical Evaluation of a TaqMan Real-Time PCR Assay for the Detection of Chikungunya Virus

Due to the general symptoms presented by the Chikungunya virus (CHIKV)-infected patients, a laboratory test is needed to differentiate CHIKV from other viral infections. The reverse transcription-quantitative real-time PCR (RT-qPCR) is a rapid and sensitive diagnostic tool, and several assays hav...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna, Andrew, Citartan, Marimuthu, Wong, Kiing Aik, Tang, Thean Hock, Sum, Magdline Sia Henry, Ch'ng, Ewe Seng
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:http://ir.unimas.my/id/eprint/42216/1/Anna%20Andrew.pdf
http://ir.unimas.my/id/eprint/42216/
https://journals.asm.org/doi/epub/10.1128/spectrum.00088-23
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Due to the general symptoms presented by the Chikungunya virus (CHIKV)-infected patients, a laboratory test is needed to differentiate CHIKV from other viral infections. The reverse transcription-quantitative real-time PCR (RT-qPCR) is a rapid and sensitive diagnostic tool, and several assays have been developed for detecting and quantifying CHIKV. Since real-time amplification efficiency varies within and between laboratories, an assay must be validated before being used on patient samples. In this study, the diagnostic performance of a TaqMan RT-qPCR assay was evaluated using synthetic RNA and archived patient samples. The cutoff quantification cycle (Cq) value for the assay was determined by experimental evidence. We found the in-house assay was highly sensitive, with a detection limit of 3.95 RNA copies/reaction. The analytical specificity of the assay was 100%. The analytical cutoff Cq value was 37, corresponding to the mean Cq value of the detection limit. Using archived samples characterized previously, the sensitivity and specificity of the assay were 76% and 100%, respectively. The inhouse assay was also compared with a commercial assay, and we found that the inhouse assay had higher sensitivity. Although further evaluation with prospective patient samples is needed in the future, this validated RT-qPCR was sensitive and specific, which shows its potential to detect CHIKV in clinical samples